Compounds > sdz mrl 953
Page last updated: 2024-09-05

sdz mrl 953 and Bacterial Infections

sdz mrl 953 has been researched along with Bacterial Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aschauer, H; Hildebrandt, J; Lam, C; Liehl, E; Macher, I; Schütze, E; Stütz, P1

Other Studies

1 other study(ies) available for sdz mrl 953 and Bacterial Infections

ArticleYear
SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:3

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Drug Interactions; Female; Galactosamine; Humans; Lethal Dose 50; Lipid A; Lipopolysaccharides; Mice; Mice, Inbred C57BL

1991